date/time interval
- August 1, 2022 - July 31, 2025
Extending the survival of HR+ breast cancer patients receiving CDK4/6 inhibitors by targeting IL17-producing gamma delta T cells
Grant
Overview
awarded by
administered by
sponsor award ID
- W81XWH-22-1-0506
Affiliation
contributor
- Zhou, Xi Kathy Co-Investigator 2022 - 2025